Acorda Therapeutics (ACOR) Misses Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Total other expense (net): -4.54M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total other expense (net): -4.54M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of $0.07, $0.11 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $127.5 million versus the consensus estimate of $128.33 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BofA maintains underperform ratings on six BDC stocks
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
